Biological analysis of an innovative biodegradable antibiotic eluting bioactive glass/gypsum composite bone cement for treating experimental chronic MRSA osteomyelitis
Authors:
Open Access
- 3 March 2021
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 12 (1) , 164-177
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Self-Setting Calcium Orthophosphate FormulationsJournal of Functional Biomaterials, 2013
- Microbiological and pharmacological tests on new antibiotic‐loaded PMMA‐based composites for the treatment of osteomyelitisJournal of Orthopaedic Research, 2011
- Biomedical applications of biodegradable polymersJournal of Polymer Science Part B: Polymer Physics, 2011
- Interfacial pH: A Critical Factor for Osteoporotic Bone RegenerationLangmuir, 2011
- Local drug delivery system for the treatment of osteomyelitis:In vitroevaluationDrug Development and Industrial Pharmacy, 2010
- Bioactive Glass and Glass-Ceramic Scaffolds for Bone Tissue EngineeringMaterials, 2010
- Modeling vancomycin release kinetics from microporous calcium phosphate ceramics comparing static and dynamic immersion conditionsActa Biomaterialia, 2008
- In vivo response of porous hydroxyapatite and β‐tricalcium phosphate prepared by aqueous solution combustion method and comparison with bioglass scaffoldsJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2007
- Self-setting properties and in vitro bioactivity of calcium sulfate hemihydrate–tricalcium silicate composite bone cementsActa Biomaterialia, 2007
- In situ SAXRD study of sol–gel induced well‐ordered mesoporous bioglasses for drug deliveryJournal of Biomedical Materials Research Part A, 2007